Skip to main content

Diagnostics
for Lung Infections

Pearl Diagnostics is changing the way clinicians diagnose lung infections. Our in vitro diagnostics identify circulating microbial extracellular vesicles.

Learn More

Recent News

Pearl Diagnostics Announces FDA 510(k) Clearance for Groundbreaking MycoMEIA Aspergillus Urine AssayNewsPearl Diagnostics Announces FDA 510(k) Clearance for Groundbreaking MycoMEIA Aspergillus Urine Assay
August 6, 2025

Pearl Diagnostics Announces FDA 510(k) Clearance for Groundbreaking MycoMEIA Aspergillus Urine Assay

BALTIMORE--(BUSINESS WIRE) 6 August 2025 11:00 AM -- Pearl Diagnostics proudly announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the MycoMEIA® Aspergillus Assay –…
John Buckley
Love0
NewsCystic Fibrosis Foundation Invests in Pearl Diagnostics to Advance Non-Invasive Detection of Pseudomonas and Aspergillus in Cystic Fibrosis
June 17, 2025

Cystic Fibrosis Foundation Invests in Pearl Diagnostics to Advance Non-Invasive Detection of Pseudomonas and Aspergillus in Cystic Fibrosis

BALTIMORE  – June 17, 2025 – Pearl Diagnostics, a Johns Hopkins University spin-off specializing in non-invasive diagnostics for lung infections, announced today it has received a strategic investment from the…
John Buckley
Love0

Why Extracellular Vesicles?

Extracellular vesicles (EVs) are made by every cell as a means to communicate. Pearl Diagnostics has discovered that microbial EVs can be detected in urine as an early indicator of lung infections.

Learn About Our Products
Pearl Diagnostics - Cell Vesicles

Our Products

Learn more about Pearl Diagnostic’s novel in vitro diagnostic assays for lung infections.

View Our Products
Have a question or inquiry?
Contact Us
Get product updates!
Join Our Mailing List
Join Our Mailing List
* indicates required




Contact Us
close slider